# Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study

> **NCT00035386** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 12 (—)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **PROCEDURE:** trans-right ventricular alcohol septal ablation (TRVASA)

## Key facts

- **NCT ID:** NCT00035386
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2003-04
- **Target enrollment:** 12 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00035386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00035386, "Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00035386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*